Freenome, Inc.(FRNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FRNM Freenome, Inc.

交易中 08-24 14:39:32 EDT

13.80

-0.01

-0.07%

最高13.88	最低13.35	成交量25.72万
今开13.69	昨收13.81	日振幅3.84%
总市值14.77亿	流通市值10.55亿	总股本1.07亿
成交额351.77万	换手率0.34%	流通股本7,643万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FRNM","market":"US","secType":"STK","nameCN":"Freenome, Inc.","latestPrice":13.8,"timestamp":1787596767718,"preClose":13.81,"halted":0,"volume":257200,"delay":0,"changeRate":-0.0007241129616219976,"floatShares":76431399,"shares":107000000,"eps":-0.069,"marketStatus":"交易中","change":-0.01,"latestTime":"08-24 14:39:32 EDT","open":13.69,"high":13.88,"low":13.3501,"amount":3517678.6184,"amplitude":0.038371,"askPrice":13.83,"askSize":103,"bidPrice":13.77,"bidSize":240,"shortable":3,"etf":0,"ttmEps":-0.069,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1718164800000,"exchange":"NASDAQ","adjPreClose":13.81,"preHourTrading":{"tag":"盘前","latestPrice":13.83,"preClose":13.81,"latestTime":"09:14 EDT","volume":2666,"amount":36885.299036,"timestamp":1787577247563,"change":0.02,"changeRate":0.001448,"amplitude":0.007241},"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"19:30 EDT","volume":144,"amount":1996.76,"timestamp":1787355007346,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.272942},"requestUrl":"/m/hq/s/FRNM","defaultTab":"news","newsList":[{"id":"1195738387","title":"FDA授予Freenome血检技术“突破性器械认定” 助力肺癌早筛全新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1195738387","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195738387?lang=zh_cn&edition=full","pubTime":"2026-08-12 21:02","pubTimestamp":1786539720,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）正式授予Freenome公司基于血液的Simplescreen™肺癌筛查检测工具“突破性器械认定”。这一认定，标志着该无创检验技术有望在降低肺癌死亡率方面扮演关键角色。简而言之，它意味着FDA将加速审查这款非侵入性、基于液体活检的创新产品，以更快地将其推向市场，惠及更多高风险人群。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185531891","title":"FDA批准Freenome的Simplescreen™ CRC血液筛查测试；雅培将在美国商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1185531891","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185531891?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:01","pubTimestamp":1785153709,"startTime":"0","endTime":"0","summary":"FDA已正式批准Freenome公司研发的Simplescreen™ CRC血液筛查测试。这款基于血液样本的结直肠癌筛查工具，将被授权给雅培（Abbott）在美国市场进行商业化推广。这一决定标志着非侵入性癌症检测领域迈出了关键一步，为患者提供了更便捷的筛查选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRNM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.freenome.com","stockEarnings":[{"period":"1week","weight":0.1946},{"period":"1month","weight":0.051},{"period":"3month","weight":0.2363},{"period":"6month","weight":0.036},{"period":"1year","weight":0.3065},{"period":"ytd","weight":0.0599}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Freenome, Inc.于2024年3月22日在开曼群岛注册成立，并于2026年7月21日在特拉华州重新注册成立。该公司是一家处于研发阶段的早期癌症检测公司，致力于开发基于血液的筛查测试，利用其专有的人工智能和机器学习多组学技术平台，以变革多种癌症乃至最终多种疾病的检测方式。该公司正在开发一系列基于血液的癌症筛查测试，包括已向美国食品药品监督管理局（FDA）提交上市前审批申请的主导产品、改进版本以及基于血液的肺癌检测。Freenome还启动了一项临床研究，以支持其肺癌检测的监管申请。","exchange":"NASDAQ","name":"Freenome, Inc.","nameEN":"Freenome, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Freenome, Inc.(FRNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Freenome, Inc.(FRNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Freenome, Inc.,FRNM,Freenome, Inc.股票,Freenome, Inc.股票老虎,Freenome, Inc.股票老虎国际,Freenome, Inc.行情,Freenome, Inc.股票行情,Freenome, Inc.股价,Freenome, Inc.股市,Freenome, Inc.股票价格,Freenome, Inc.股票交易,Freenome, Inc.股票购买,Freenome, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Freenome, Inc.(FRNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Freenome, Inc.(FRNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}